| 1077 |
increased |
increased serotonin level
(MP:0010069)
|
serotonin
(CHEBI:28790)
|
1320: Increased, extracellular serotonin
|
| 84 |
occurrence |
protein binding
(GO:0005515)
|
Selenium-Binding Proteins
(MESH:D051137)
|
261: Binding, SH-/selen-proteins
|
| 949 |
occurrence |
transcription, RNA-templated
(GO:0001172)
|
segmented viral genome
(GO:0019017)
|
2192: Influenza A Virus production increased
|
| 893 |
decreased |
abnormal palatal shelf fusion at midline
(MP:0009887)
|
secondary palate
(UBERON:0001716)
|
None
|
| 1096 |
increased |
palatal shelves fail to meet at midline
(MP:0009888)
|
secondary palate
(UBERON:0001716)
|
2041: Decrease, facial prominence outgrowth
|
| 891 |
decreased |
|
secondary palatal shelf
(UBERON:0005619)
|
None
|
| 786 |
decreased |
pattern recognition receptor signaling pathway
(GO:0002221)
|
RNA viral genome
(GO:0019022)
|
None
|
| 880 |
occurrence |
cellular response to exogenous dsRNA
(GO:0071360)
|
RNA viral genome
(GO:0019022)
|
1901: Interferon-I antiviral response, antagonized by SARS-CoV-2
|
| 1059 |
decreased |
retinoic acid biosynthetic process
(GO:0002138)
|
retinal dehydrogenase 1
(PR:000003920)
|
1880: Decreased, ALDH1A (RALDH) enzyme activity
|
| 785 |
morphological change |
retina layer formation
(GO:0010842)
|
retina
(UBERON:0000966)
|
1877: Altered, retinal layer structure
|
| 625 |
increased |
inflammatory response
(GO:0006954)
|
respiratory system
(UBERON:0001004)
|
1226: Increased Respiratory irritability and Chronic Cough,
|
| 620 |
increased |
|
Respiratory Hypersensitivity
(MESH:D012130)
|
1223: Trigeminal and/or vagal nerve excitation causes Airway Hyper-responsiveness,Cough, Dyspnea
|
| 1141 |
increased |
abnormal reproductive system development
(MP:0003936)
|
reproductive organ
(UBERON:0003133)
|
2415: Precocious puberty
|
| 143 |
abnormal |
developmental process
(GO:0032502)
|
reproductive organ
(UBERON:0003133)
|
364: Impaired development of, Reproductive organs
|
| 443 |
occurrence |
autophagic cell death
(GO:0048102)
|
renal tubule
(UBERON:0009773)
|
818: Occurrence, Cytoplasmic vacuolization (Renal tubule)
|
| 444 |
occurrence |
Dilatation
(MESH:D004106)
|
renal tubule
(UBERON:0009773)
|
823: Occurrence, Cystic dilatation (renal tubule)
|
| 764 |
increased |
cellular response to oxidative stress
(GO:0034599)
|
reactive oxygen species
(CHEBI:26523)
|
1869: Diminished protective oxidative stress response
|
| 765 |
increased |
response to reactive oxygen species
(GO:0000302)
|
reactive oxygen species
(CHEBI:26523)
|
2 Events
|
| 766 |
occurrence |
regulation of response to reactive oxygen species
(GO:1901031)
|
reactive oxygen species
(CHEBI:26523)
|
1634: Increase, Oxidative DNA damage
|
| 579 |
increased |
|
reactive oxygen species
(CHEBI:26523)
|
None
|
| 667 |
increased |
biosynthetic process
(GO:0009058)
|
reactive oxygen species
(CHEBI:26523)
|
None
|
| 120 |
increased |
reactive oxygen species biosynthetic process
(GO:1903409)
|
reactive oxygen species
(CHEBI:26523)
|
1115: Increase, Reactive oxygen species
|
| 261 |
increased |
signaling
(GO:0023052)
|
RAC-beta serine/threonine-protein kinase
(PR:000003912)
|
484: Activation, AKT2
|
| 379 |
increased |
pyruvate dehydrogenase activity
(GO:0004738)
|
pyruvate dehydrogenase [ubiquinone]
(PR:000023575)
|
726: Increased, Induction of pyruvate dehydrogenase (PDH)
|
| 380 |
decreased |
pyruvate dehydrogenase activity
(GO:0004738)
|
Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (rat)
(PR:Q63065)
|
724: Inhibition, Pyruvate dehydrogenase kinase (PDK) enzyme
|